MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodies [0.03%]
阿尔茨海默病患者接受单克隆抗体治疗时用于监测与淀粉样蛋白相关影像学异常的磁共振成像协议和序列
Federica Agosta,Giordano Cecchetti,Edoardo G Spinelli et al.
Federica Agosta et al.
Purpose of review: This review provides an updated overview of amyloid-related imaging abnormalities (ARIA) associated with antiamyloid monoclonal antibodies (mAbs) in Alzheimer's disease (AD). Following regulatory approv...
Rachael Matthews,Brendan F Sargent,Steven McKeever et al.
Rachael Matthews et al.
Purpose of review: Viral encephalitis is a potentially devastating condition of cerebral inflammation manifest as a combination of fever, altered mentation, and sometimes focal neurological signs and seizures. In this rev...
Sara P Dias,Tamar Akhvlediani,Raphael Bernard-Valnet et al.
Sara P Dias et al.
Purpose of review: Neurological infections are a significant cause of morbidity and mortality. This review aims to summarize current insights and developments for sex and gender differences in the epidemiology, clinical p...
Dennis Yeow,Laura I Rudaks,Kishore R Kumar
Dennis Yeow
Purpose of review: The number of known genetic movement disorders and potential treatments for these disorders have grown rapidly over the last few decades. Despite this, genetic testing for movement disorders remains rel...
Alexandre Boutet,Jürgen Germann,Alfonso Fasano
Alexandre Boutet
Purpose of review: Imaging plays a key role in neuromodulation for Parkinson's disease, particularly for deep brain stimulation (DBS), which is the most frequently employed neuromodulatory treatment. Its role is rapidly e...
Anthi Papouli,James H Cole
Anthi Papouli
Purpose of review: This review explores the use of brain age estimation from MRI scans as a biomarker of brain health. With disorders like Alzheimer's and Parkinson's increasing globally, there is an urgent need for early...
Ashley Madera,Clare Schrodt,Adys Mendizabal
Ashley Madera
Purpose of review: Disparities in care and outcomes are well described in common neurologic disorders; however, less is known about disparities in rare diseases such as Huntington's disease (HD). This review summarizes HD...
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders [0.03%]
神经精神病学高动能障碍差异研究中的挑战
Marisela E Dy-Hollins,Adys Mendizabal,Alexander C Tsai
Marisela E Dy-Hollins
Purpose of review: The purpose of this review is to highlight challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders, specifically Tourette syndrome and Huntington's disease. ...
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1 [0.03%]
肌迟缓性营养不良1型的临床和治疗进展
Masanori P Takahashi
Masanori P Takahashi
Purpose of review: Myotonic dystrophy type 1 (DM1) is a genetically mediated, multisystemic neuromuscular disorder with significant phenotypic heterogeneity. This review aimed to summarize recent advances in clinical unde...